Morphologic Types of Tricuspid Regurgitation: Characteristics and Prognostic Implications.


Journal

JACC. Cardiovascular imaging
ISSN: 1876-7591
Titre abrégé: JACC Cardiovasc Imaging
Pays: United States
ID NLM: 101467978

Informations de publication

Date de publication:
03 2019
Historique:
received: 18 06 2018
revised: 17 09 2018
accepted: 20 09 2018
entrez: 9 3 2019
pubmed: 9 3 2019
medline: 14 1 2020
Statut: ppublish

Résumé

Tricuspid regurgitation (TR) is classified according to different morphologic types based on the underlying mechanisms: primary, secondary, and isolated TR. Primary TR is caused by an anatomical abnormality of the tricuspid valve apparatus. Secondary TR is caused by dilation of the tricuspid valve annulus, related to right ventricular (RV), or right atrial remodeling and increased RV pressures (often secondary to left-sided heart disease). Isolated TR can exist in patients without increased RV pressures and is frequently associated with atrial fibrillation. Two-dimensional echocardiography plays a pivotal role in the assessment of the etiology and severity of TR. Views from 3-dimensional techniques have significantly increased the understanding of the pathophysiology of each morphologic type of TR (leaflet damage, annular dilation, and distinct patterns of right-heart remodeling). The following review will describe the etiology, anatomical and functional characteristics, and outcomes of each morphologic type of TR, and furthermore addresses challenging pitfalls in the referral for tricuspid valve intervention.

Identifiants

pubmed: 30846123
pii: S1936-878X(19)30104-4
doi: 10.1016/j.jcmg.2018.09.027
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

491-499

Informations de copyright

Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Auteurs

Edgard A Prihadi (EA)

Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands; Department of Cardiology, ZNA Middelheim Hospital, Antwerpen, Belgium.

Victoria Delgado (V)

Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.

Martin B Leon (MB)

Department of Cardiology, Columbia University Medical Center, New York, New York.

Maurice Enriquez-Sarano (M)

Cardiovascular Diseases Division, Mayo Clinic, Rochester, Minnesota.

Yan Topilsky (Y)

Department of Cardiology, Tel Aviv Medical Center, Sackler Faculty of Medicine, Tel Aviv, Israel.

Jeroen J Bax (JJ)

Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: j.j.bax@lumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH